DOI: https://dx.doi.org/10.18565/pharmateca.2024.5.61-65
Аюпова К.Р., Юсупова Л.А.
Казанская государственная медицинская академия – филиал Российской медицинской академии непрерывного профессионального образования, Казань, Россия
1. Alexis A.F., Callender V.D., Baldwin H.E., et al. Global epidemiology and the clinical spectrum of rosacea, highlighting skin of color: a Review and experience of clinical practice experience. J Am Acad Dermatol. 2019;80(6):1722–29.
2. Аюпова К.Р., Юсупова Л.А. Современные особенности патогенетических механизмов розацеа. Фарматека. 2022;29(8):43–7.
3. Юсупова Л.А. Современное состояние проблемы эксфолиативного дерматита. Лечащий врач. 2019;11:6–8
4. Zujko-Kowalska K., Maslowska J., Knas-Dawidziuk M., et al. Dietary antioxidants may support cosmetic treatment of patients with rosacea. Antioxidants (Basel). 2024;13(3):381.
5. Кажжанова А.М., Юсупова Л.А. Патогенетические механизмы гнездной алопеции. Фарматека. 2023; 29(8):47–51.
6. Turkmen D. Serum bilirubin and uric acid antioxidant levels in rosacea patients. J Cosmet Dermatol. 2020;19(10):2717–20.
7. Юсупова Л.А. Современный взгляд на проблему старения кожи. Лечащий врач. 2017;6:75.
8. Halioua B., Cribier B., Frey M., Tan J. A sense of stigmatization in patients with rosacea. J Eur Acad Dermatol Venerol. 2017;31(1):163–68.
9. Yang F., Zhang K., Song D., et al. A cross-sectional study on the relationship between rosacea severity and quality of life or psychological state. Clin Cosmet Investing Dermatol. 2022;15:2807–16.
10. Yamasaki K., Miyachi Yu. Perspectives on rosacea patient characteristics and quality of life using baseline data from a phase 3 clinical study conducted in Japan. J Dermatol. 2022;49:1221–27.
11. Geng R.S.Q, Bourkas A.N., Mufti A.N., Sibbalt R.G. Rosacea: pathogenesis and therapeutic correlates. J Cutan Med Surg. 2024;28(2):178–89.
12. Cui M., Honore P., Zhong S., et al. TRPV1 receptors in the central nervous system CNS play a key role in role in broad-spectrum analgesia of TRPV1 antagonists. J Neurosci. 2006;26(37):9385–93.
13. Bailey R.L., Braden J.E. TRPV channels and vascular function. Acta Physiol (Ox)). 2011;203(1):99–116.
14. Kostyuchuk E.M., Lisowsky P., Jarczak J., et al. Cathelicidins: a family of antimicrobial peptides. Review. Mol Biol Rep. 2012;39(12):10957–70.
15. Oliveira-Nascimento L., Massari P., Wetzler L.M. The role of TLP2 in infection and immunity. Front Immunol. 2012;3:79.
16. Reinholz M., Ruzicka T., Steinhoff M., etc. The pathogenesis and clinical presentation of rosacea as the key to symptom-oriented therapy. J Dtsch Dermatol Ges. 2016;14:4–15.
17. Meyer-Hoffert U., Schroeder J.M. Epidermal proteases in the pathogenesis of rosacea. J Investing Dermatol Symp Proc. 2011;15(1):16-23.
18. Villalta P.K., Rocic P., Townsley M. I. Role of MMP2 and MMP9 in TPPV4-induced lung injury. Am J Phisiol Lung Cell Mol Physiol. 2014;307(8):L652–59.
19. Alalwani S.M., Sierigk J., Herr S. et al. The antimicrobial peptide LL-37 modulates the inflammatory and host defense response of human neutrophils. Euro J Immunol. 2010;40(4):1118–26.
20. Yoon S.H., Hwang I., Lee E., et al. Antimicrobial Peptid LL-37 drives rosacea-like skin inflammation in NLRP3-dependent manner. J Invest Dermatol. 2021;141(12):2885–94.e5.
21. Buhl T., Sulk M., Nowak P., et al. Molecular and morphological characterization of inflammatory infiltrate in rosacea reveals activation of the Th1 and Th17 pathways. J Invest Dermatol. 2015;135(9):2198–2208.
22. Plewig G., Kligman A.M. Acne and rosacea. Springer Science & Business Media; 2012.
23. Chang A.L.S., Raber I., Xu J., et al. Assessment of the genetic basis of rosacea using a by genome-wide associative study. J Invest Dermatol. 2015;135(6):1548–55.
24. Forton F.M.N. The pathogenic role of demodex mites in rosacea: a potential therapeutic target already in erythematoteleangioectatic rosacea? Dermatol Ther (Heidelb). 2020;10(6):1229–53.
25. Lacey N., Russell-Hallinan A., Zouboulis C.C., Powell F.C. Demodex mites modulate sebocyte immune reaction: a possible role in the pathogenesis of rosacea. Br J Dermatol. 2018;179(2):420–30.
26. Suerbaum S., Michetti P. Helicobacter pylori infection. N Engl J Med. 2002;347(15):1175–86.
27. Nakajima S., Bamba N., Hattori T. Histological aspects and the role of mast cells in Helicobacter pylori-infected gastritis. Aliment Pharmacol Ther, 2004; 20 (Suppl 1):165–70.
28. Аюпова К.Р., Юсупова Л.А. Розацеа: тригерные факторы и сопутствующие заболевания. Фарматека. 2023;29(8):20–6.
29. Yamasaki K., Gallo R. L. The Molecular pathology of rosacea. J Dermatol Sci. 2009;55(2):77–81.
Автор для связи: Камила Равилевна Аюпова, соискатель кафедры дерматовенерологии и косметологии, Казанская государственная медицинская академия – филиал Российской медицинской академии непрерывного профессионального образования, Казань, Россия; skinderma@rambler.ru
ORCID eLibrary SPIN:
К.Р. Аюпова (K.R. Ayupova), ORCID: https://orcid.org/0000-0002-2179-1214
Л.А. Юсупова (L.A. Yusupova), ORCID: https://orcid.org/0000-0001-8937-2158; eLibrary SPIN: 5743-6872